Literature DB >> 15608056

Vitamin C conjugates of genotoxic lipid peroxidation products: structural characterization and detection in human plasma.

John Sowell1, Balz Frei, Jan F Stevens.   

Abstract

alpha,beta-Unsaturated aldehydes such as 4-hydroxy-2-nonenal (HNE) and other electrophilic lipid peroxidation (LPO) products may contribute to the pathogenesis of cancer, cardiovascular diseases, and other age-related diseases by cytotoxic, genotoxic, and proinflammatory mechanisms. The notion that vitamin C (ascorbic acid) acts as a biological antioxidant has been challenged recently by an in vitro study showing that ascorbic acid promotes, rather than inhibits, the formation of genotoxic LPO products from the lipid hydroperoxide, hydroperoxy octadecadienoic acid [Lee, S. H., Oe, T. & Blair, I. A. (2001) Science 292, 2083-2086]. Here, we demonstrate that ascorbic acid acts as a nucleophile and forms Michael-type conjugates with electrophilic LPO products. Several ascorbyl-LPO product conjugates, resulting from the interaction of ascorbic acid with hydroperoxy octadecadienoic acid in vitro, were identified by tandem MS, including ascorbyl conjugates of HNE, 4-oxo-2-nonenal, and presumably, 12-oxo-9-hydroxy-10-dodecenoic acid. The same ascorbyl-LPO product conjugates were detected in human plasma. The concentration of the ascorbyl-HNE conjugate in plasma from 11 healthy subjects was found to be 1.30 +/- 0.74 microM (mean +/- SD). Our data identify ascorbylation (vitamin C conjugation) as a previously unrecognized, biologically relevant pathway for the elimination of electrophilic LPO products, and have implications for the prevention and treatment of chronic inflammatory diseases, as well as the development of novel biomarkers of oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15608056      PMCID: PMC539811          DOI: 10.1073/pnas.0408433102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 2.  The low-density lipoprotein pathway and its relation to atherosclerosis.

Authors:  J L Goldstein; M S Brown
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

Review 3.  Biochemical, structural, and functional properties of oxidized low-density lipoprotein.

Authors:  H Esterbauer; M Dieber-Rotheneder; G Waeg; G Striegl; G Jürgens
Journal:  Chem Res Toxicol       Date:  1990 Mar-Apr       Impact factor: 3.739

Review 4.  Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids.

Authors:  W A Pryor; N A Porter
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

5.  Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages.

Authors:  H F Hoff; J O'Neil
Journal:  Atherosclerosis       Date:  1988-03       Impact factor: 5.162

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids.

Authors:  A Benedetti; M Comporti; H Esterbauer
Journal:  Biochim Biophys Acta       Date:  1980-11-07

8.  Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal.

Authors:  G Jürgens; J Lang; H Esterbauer
Journal:  Biochim Biophys Acta       Date:  1986-01-03

9.  Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde.

Authors:  H F Hoff; J O'Neil
Journal:  J Lipid Res       Date:  1993-07       Impact factor: 5.922

10.  Antioxidant defenses and lipid peroxidation in human blood plasma.

Authors:  B Frei; R Stocker; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

View more
  6 in total

Review 1.  4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product.

Authors:  Rudolf J Schaur; Werner Siems; Nikolaus Bresgen; Peter M Eckl
Journal:  Biomolecules       Date:  2015-09-30

2.  Convenient and efficient syntheses of 4-hydroxy-2(E)-nonenal and 4-oxo-2(E)-nonenal.

Authors:  Reshma F Kurangi; Santosh G Tilve; Ian A Blair
Journal:  Lipids       Date:  2006-09       Impact factor: 1.646

3.  Ameliorative effects of herbal combinations in hyperlipidemia.

Authors:  Nishant P Visavadiya; A V R L Narasimhacharya
Journal:  Oxid Med Cell Longev       Date:  2011-09-15       Impact factor: 6.543

Review 4.  Role of the lipoperoxidation product 4-hydroxynonenal in the pathogenesis of severe malaria anemia and malaria immunodepression.

Authors:  Evelin Schwarzer; Paolo Arese; Oleksii A Skorokhod
Journal:  Oxid Med Cell Longev       Date:  2015-04-19       Impact factor: 6.543

5.  Asparagus root regulates cholesterol metabolism and improves antioxidant status in hypercholesteremic rats.

Authors:  Nishant P Visavadiya; A V R L Narasimhacharya
Journal:  Evid Based Complement Alternat Med       Date:  2007-08-27       Impact factor: 2.629

6.  Prophylactic Role of Averrhoa carambola (Star Fruit) Extract against Chemically Induced Hepatocellular Carcinoma in Swiss Albino Mice.

Authors:  Ritu Singh; Jyoti Sharma; P K Goyal
Journal:  Adv Pharmacol Sci       Date:  2014-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.